Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02849678 · ClinicalTrials.gov registry record · NA

A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery

A NA study, sponsored by Jacques E. Chelly.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT02849678 is a NA study that has completed, run by Jacques E. Chelly. The registered enrollment target is 68 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02849678, a NA study, has completed, sponsored by Jacques E. Chelly.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

This research study is testing whether the local anesthetic lidocaine is as effective as ropivacaine for post-operative pain control in continuous thoracic paravertebral nerve blocks. Ropivacaine and Lidocaine are FDA-approved drugs that has been successfully used in this hospital for post-operative pain control for the past few years, thus has become the standard drugs used for this nerve block. Lidocaine has numerous potential advantages over ropivacaine, such as faster onset of action, better safety profile and greater anti-inflammatory action. Catheters placed near both sides of a patient's spine for postoperative pain control are called thoracic paravertebral nerve blocks and are a part of routine care. Through those catheters, a "numbing" medication, or local anesthetic, to block the transmission of pain from the surgical incision to the spinal cord, thus reducing pain. The research part of the study is whether subjects will receive either the local anesthetic lidocaine or ropivacaine. The goal of this study is to determine whether the lidocaine controls pain better and facilitates a faster recovery after abdominal surgery than ropivacaine. In this research study, the investigators will compare patient-reported pain scores, any additional pain medication requirements for adequate pain control, time it takes for bowel function to return to normal following surgery, as well as the incidence of any side effects, such as numbness and weakness, subjects may experience between those receiving lidocaine versus those receiving ropivacaine. The investigators will screen 100 patients and enroll 60 subjects into this study.

Interventions

  • DRUG Lidocaine
  • DRUG Ropivacaine

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2008-01
Est. Completion 2016-05
Phase NA

Sponsor

Jacques E. Chelly

10 total trials

What the Registry Record Tells You About NCT02849678

The ClinicalTrials.gov registry entry for NCT02849678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jacques E. Chelly, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.

NCT02849678 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02849678 about?

NCT02849678 is a clinical study titled "A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery". This research study is testing whether the local anesthetic lidocaine is as effective as ropivacaine for post-operative pain control in continuous thoracic paravertebral nerve blocks. Ropivacaine and Lidocaine are FDA-approved drugs that has been successfully used in this hospital for post-operative...

What is the current status of trial NCT02849678?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2008-01. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02849678?

The interventions under investigation include: Lidocaine (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT02849678?

This trial is sponsored by Jacques E. Chelly, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.